Loading institutional data...
Loading institutional data...
Held by 191 of 5,944 reporting institutions (91th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| ACCO | $392M | 9.9× | 10.3× | 0.3× | -8.5% | 32.8% | 2.7% | 6.2% | 2.8% | 7.0× | 191 |
Peers = companies sharing ACCO's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $27M dividends + $15M buybacks = $42M returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~5.5% on $837M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B 100.0% | $1.67B 100.0% | $1.83B 100.0% | $1.95B 100.0% | $2.03B 100.0% | $1.66B 100.0% | $1.96B 100.0% | $1.94B 100.0% | $1.95B 100.0% | $1.56B 100.0% |
| Cost of Revenue | $1.02B 67.2% | $1.11B 66.7% | $1.23B 67.4% | $1.40B 71.6% | $1.41B 69.6% | $1.16B 70.3% | $1.32B 67.6% | $1.31B 67.7% | $1.29B 66.3% | $1.04B 66.9% |
| Cost of Products | — | — | — | — | — | — | — | — | $1.29B 66.3% | $1.04B 66.9% |
| Gross Profit | $500.0M 32.8% | $555.4M 33.3% | $598.3M 32.6% | $552.3M 28.4% | $614.9M 30.4% | $492.4M 29.7% | $633.5M 32.4% | $627.8M 32.3% | $657.3M 33.7% | $514.9M 33.1% |
| Research & Development | $22.0M 1.4% | $23.0M 1.4% | $25.8M 1.4% | $26.3M 1.4% | $26.6M 1.3% | $19.7M 1.2% | $21.8M 1.1% | $23.8M 1.2% | $23.5M 1.2% | $21.0M 1.3% |
| Selling, General & Admin | $346.7M 22.7% | $365.7M 21.9% | $393.5M 21.5% | $376.7M 19.3% | $392.6M 19.4% | $336.3M 20.3% | $389.9M 19.9% | $392.4M 20.2% | $415.5M 21.3% | $328.8M 21.1% |
| Total Operating Expenses | $407.7M 26.7% | $592.4M 35.6% | $553.6M 30.2% | $517.5M 26.6% | $463.9M 22.9% | $380.0M 23.0% | $437.3M 22.4% | $440.8M 22.7% | $472.8M 24.3% | $355.8M 22.9% |
| Operating Income | $92.3M 6.1% | -$37.0M -2.2% | $44.7M 2.4% | $34.8M 1.8% | $151.0M 7.5% | $112.4M 6.8% | $196.2M 10.0% | $187.0M 9.6% | $184.5M 9.5% | $159.1M 10.2% |
| Interest Expense | $45.8M 3.0% | $52.6M 3.2% | $58.6M 3.2% | $45.6M 2.3% | $46.3M 2.3% | $38.8M 2.3% | $43.2M 2.2% | $41.2M 2.1% | $41.1M 2.1% | $49.3M 3.2% |
| Interest & Investment Income | $9.4M 0.6% | $7.5M 0.5% | $7.1M 0.4% | $8.3M 0.4% | $1.9M 0.1% | $1.0M 0.1% | $3.2M 0.2% | $4.4M 0.2% | $5.8M 0.3% | $6.4M 0.4% |
| Other Income (Expense), net | -$4.3M -0.3% | $900K 0.1% | -$4.5M -0.2% | $12.9M 0.7% | -$3.1M -0.2% | -$1.6M -0.1% | $1.8M 0.1% | -$1.6M -0.1% | $400K 0.0% | -$1.4M -0.1% |
| Pretax Income | $49.1M 3.2% | -$87.3M -5.2% | -$13.1M -0.7% | $14.9M 0.8% | $111.4M 5.5% | $78.6M 4.7% | $163.5M 8.4% | $157.9M 8.1% | $158.1M 8.1% | $125.1M 8.0% |
| Income Tax Expense | $7.8M 0.5% | $14.3M 0.9% | $8.7M 0.5% | $28.1M 1.4% | $9.5M 0.5% | $16.6M 1.0% | $56.7M 2.9% | $51.2M 2.6% | $24.0M 1.2% | $29.6M 1.9% |
| Net Income | $41.3M 2.7% | -$101.6M -6.1% | -$21.8M -1.2% | -$13.2M -0.7% | $101.9M 5.0% | $62.0M 3.7% | $106.8M 5.5% | $106.7M 5.5% | $131.7M 6.8% | $95.5M 6.1% |
| Per Share | ||||||||||
| EPS (Basic) | $0.45 | $-1.06 | $-0.23 | $-0.14 | $1.07 | $0.65 | $1.07 | $1.02 | $1.22 | $0.89 |
| EPS (Diluted) | $0.44 | $-1.06 | $-0.23 | $-0.14 | $1.05 | $0.65 | $1.06 | $1.00 | $1.19 | $0.87 |
| Weighted Avg Shares (Basic) | 92.1M | 95.6M | 95.3M | 95.3M | 95.5M | 94.9M | 99.5M | 104.8M | 108.1M | 107.0M |
| Weighted Avg Shares (Diluted) | 94.0M | 95.6M | 95.3M | 95.3M | 97.1M | 96.1M | 101.0M | 107.0M | 110.9M | 109.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 53th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 41.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 67.7 | 67.6 | 70.3 | 69.6 | 71.6 | 67.4 | 66.7 | 67.2 |
| Gross Profit | 32.3 | 32.4 | 29.7 | 30.4 | 28.4 | 32.6 | 33.3 | 32.8 |
| R&D | 1.2 | 1.1 | 1.2 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 |
| SG&A | 20.2 | 19.9 | 20.3 | 19.4 | 19.3 | 21.5 | 21.9 | 22.7 |
| Operating Income | 9.6 | 10.0 | 6.8 | 7.5 | 1.8 | 2.4 | -2.2 | 6.1 |
| Income Tax | 2.6 | 2.9 | 1.0 | 0.5 | 1.4 | 0.5 | 0.9 | 0.5 |
| Net Income | 5.5 | 5.5 | 3.7 | 5.0 | -0.7 | -1.2 | -6.1 | 2.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ACCO: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.